arrow_back Back to App

National Plan to End Parkinson's: Research, Care, and Support

This act establishes a national project aimed at preventing and curing Parkinson's disease. This means better coordination of research, faster diagnoses, and improved care for individuals affected by the disease and their families. The goal is to reduce the financial and health burden associated with Parkinson's.
Key points
Creation of the National Parkinson's Project to coordinate efforts in preventing and curing the disease.
Establishment of an Advisory Council comprising experts, patients, and caregivers to advise on research and care matters.
Improved coordination of federal programs, accelerated drug development, and enhanced early diagnosis of Parkinson's.
Increased focus on high-risk populations and reduction of health disparities in access to care.
Annual reports assessing progress and the impact of the disease on the physical, mental, and social health of patients and their caregivers.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4851
Sponsor: Sen. Capito, Shelley Moore [R-WV]
Process start date: 2022-09-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

National Plan to End Parkinson’s Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4851.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-09-14.

What are the main provisions?

Key points include:

  • Creation of the National Parkinson's Project to coordinate efforts in preventing and curing the disease.
  • Establishment of an Advisory Council comprising experts, patients, and caregivers to advise on research and care matters.
  • Improved coordination of federal programs, accelerated drug development, and enhanced early diagnosis of Parkinson's.
  • Increased focus on high-risk populations and reduction of health disparities in access to care.
  • Annual reports assessing progress and the impact of the disease on the physical, mental, and social health of patients and their caregivers.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Capito, Shelley Moore [R-WV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health